Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy BELLUS Health stock

Learn how to easily invest in BELLUS Health stock.

BELLUS Health Inc. is a biotechnology business based in the US. BELLUS Health shares (BLU) are listed on the NASDAQ and all prices are listed in US Dollars. BELLUS Health employs 40 staff and has a trailing 12-month revenue of around $16,000.

How to buy shares in BELLUS Health

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BLU – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

BELLUS Health stock price (NASDAQ: BLU)

Use our graph to track the performance of BLU stocks over time.

BELLUS Health shares at a glance

Information last updated 2022-09-25.
Latest market close$10.23
52-week range$4.98 - $12.69
50-day moving average $10.76
200-day moving average $8.32
Wall St. target price$17.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.81

Buy BELLUS Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BELLUS Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BELLUS Health price performance over time

Historical closes compared with the close of $10.23 from 2022-09-23

1 week (2022-09-19) -7.08%
1 month (2022-08-26) -10.03%
3 months (2022-06-24) 22.96%
6 months (2022-03-23) 61.87%
1 year (2021-09-24) 60.60%
2 years (2020-09-25) 371.43%
3 years (2019-09-26) 63.94%
5 years (2017-09-25) 3,223.59%

BELLUS Health financials

Revenue TTM $16,000
Gross profit TTM $16,000
Return on assets TTM -22.09%
Return on equity TTM -37.16%
Profit margin 0%
Book value $2.47
Market capitalisation $1.3 billion

TTM: trailing 12 months

BELLUS Health share dividends

We're not expecting BELLUS Health to pay a dividend over the next 12 months.

Have BELLUS Health's shares ever split?

BELLUS Health's shares were split on a 277:1000 basis on 18 August 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 277 shares. This wouldn't directly have changed the overall worth of your BELLUS Health shares – just the quantity. However, indirectly, the new 261% higher share price could have impacted the market appetite for BELLUS Health shares which in turn could have impacted BELLUS Health's share price.

BELLUS Health share price volatility

Over the last 12 months, BELLUS Health's shares have ranged in value from as little as $4.98 up to $12.69. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BELLUS Health's is -0.5842. This would suggest that BELLUS Health's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BELLUS Health has bucked the trend.

BELLUS Health overview

BELLUS Health Inc. , a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada. .

Frequently asked questions

What percentage of BELLUS Health is owned by insiders or institutions?
Currently 11.266% of BELLUS Health shares are held by insiders and 88.908% by institutions.
How many people work for BELLUS Health?
Latest data suggests 40 work at BELLUS Health.
When does the fiscal year end for BELLUS Health?
BELLUS Health's fiscal year ends in December.
Where is BELLUS Health based?
BELLUS Health's address is: 275 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4A7
What is BELLUS Health's ISIN number?
BELLUS Health's international securities identification number is: CA07987C2040
What is BELLUS Health's CUSIP number?
BELLUS Health's Committee on Uniform Securities Identification Procedures number is: 07986A100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site